Literature DB >> 24018988

Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes.

Limei Liu1, Kazuaki Nagashima, Takao Yasuda, Yanjun Liu, Hai-Rong Hu, Guang He, Bo Feng, Mingming Zhao, Langen Zhuang, Taishan Zheng, Theodore C Friedman, Kunsan Xiang.   

Abstract

AIMS/HYPOTHESIS: More than 90% of Chinese familial early-onset type 2 diabetes mellitus is genetically unexplained. To investigate the molecular aetiology, we identified and characterised whether mutations in the KCNJ11 gene are responsible for these families.
METHODS: KCNJ11 mutations were screened for 96 familial early-onset type 2 diabetic probands and their families. Functional significance of the identified mutations was confirmed by physiological analysis, molecular modelling and population survey.
RESULTS: Three novel KCNJ11 mutations, R27H, R192H and S116F117del, were identified in three families with early-onset type 2 diabetes mellitus. Mutated KCNJ11 with R27H or R192H markedly reduced ATP sensitivity (E23K>R27H>C42R>R192H>R201H), but no ATP-sensitive potassium channel currents were detected in the loss-of-function S116F117del channel in vitro. Molecular modelling indicated that R192H had a larger effect on the channel ATP-binding pocket than R27H, which may qualitatively explain why the ATP sensitivity of the R192H mutation is seven times less than R27H. The shape of the S116F117del channel may be compressed, which may explain why the mutated channel had no currents. Discontinuation of insulin and implementation of sulfonylureas for R27H or R192H carriers and continuation/switch to insulin therapy for S116F117del carriers resulted in good glycaemic control. CONCLUSIONS/
INTERPRETATION: Our results suggest that genetic diagnosis for the KCNJ11 mutations in familial early-onset type 2 diabetes mellitus may help in understanding the molecular aetiology and in providing more personalised treatment for these specific forms of diabetes in Chinese and other Asian patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24018988      PMCID: PMC5333983          DOI: 10.1007/s00125-013-3031-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  44 in total

1.  Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification.

Authors:  Scott Pegan; Christine Arrabit; Wei Zhou; Witek Kwiatkowski; Anthony Collins; Paul A Slesinger; Senyon Choe
Journal:  Nat Neurosci       Date:  2005-02-20       Impact factor: 24.884

2.  Spontaneous recovery from hyperglycemia by regeneration of pancreatic beta-cells in Kir6.2G132S transgenic mice.

Authors:  Kazunobu Oyama; Kohtaro Minami; Katsuhiko Ishizaki; Masanori Fuse; Takashi Miki; Susumu Seino
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

3.  The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation.

Authors:  T Klupa; E L Edghill; J Nazim; J Sieradzki; S Ellard; A T Hattersley; M T Malecki
Journal:  Diabetologia       Date:  2005-04-19       Impact factor: 10.122

4.  Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes.

Authors:  A Doria; Y Yang; M Malecki; S Scotti; J Dreyfus; C O'Keeffe; T Orban; J H Warram; A S Krolewski
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

5.  Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism.

Authors:  Mariko Suchi; Courtney M MacMullen; Paul S Thornton; N Scott Adzick; Arupa Ganguly; Eduardo D Ruchelli; Charles A Stanley
Journal:  Mod Pathol       Date:  2006-01       Impact factor: 7.842

Review 6.  Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice.

Authors:  S Seino; T Iwanaga; K Nagashima; T Miki
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

7.  Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.

Authors:  Anna L Gloyn; Ewan R Pearson; Jennifer F Antcliff; Peter Proks; G Jan Bruining; Annabelle S Slingerland; Neville Howard; Shubha Srinivasan; José M C L Silva; Janne Molnes; Emma L Edghill; Timothy M Frayling; I Karen Temple; Deborah Mackay; Julian P H Shield; Zdenek Sumnik; Adrian van Rhijn; Jerry K H Wales; Penelope Clark; Shaun Gorman; Javier Aisenberg; Sian Ellard; Pål R Njølstad; Frances M Ashcroft; Andrew T Hattersley
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

8.  Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor.

Authors:  N Inagaki; T Gonoi; J P Clement; N Namba; J Inazawa; G Gonzalez; L Aguilar-Bryan; S Seino; J Bryan
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

9.  Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.

Authors:  P Froguel; H Zouali; N Vionnet; G Velho; M Vaxillaire; F Sun; S Lesage; M Stoffel; J Takeda; P Passa
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

10.  A novel mutation, Ser159Pro in the NeuroD1/BETA2 gene contributes to the development of diabetes in a Chinese potential MODY family.

Authors:  Limei Liu; Hiroto Furuta; Asako Minami; Taishan Zheng; Weiping Jia; Kishio Nanjo; Kunsan Xiang
Journal:  Mol Cell Biochem       Date:  2007-04-18       Impact factor: 3.396

View more
  9 in total

1.  The E23K and A190A variations of the KCNJ11 gene are associated with early-onset type 2 diabetes and blood pressure in the Chinese population.

Authors:  Langen Zhuang; Yu Zhao; Weijing Zhao; Ming Li; Ming Yu; Ming Lu; Rong Zhang; Xiaoxu Ge; Taishan Zheng; Can Li; Jun Yin; Jingyuan Yin; Yuqian Bao; Limei Liu; Weiping Jia; Yanjun Liu
Journal:  Mol Cell Biochem       Date:  2015-03-01       Impact factor: 3.396

2.  Approach to the Patient with MODY-Monogenic Diabetes.

Authors:  David T Broome; Kevin M Pantalone; Sangeeta R Kashyap; Louis H Philipson
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

Review 3.  How can maturity-onset diabetes of the young be identified among more common diabetes subtypes?

Authors:  Jana Urbanova; Ludmila Brunerova; Jan Broz
Journal:  Wien Klin Wochenschr       Date:  2019-09-06       Impact factor: 1.704

4.  Impact of Genetic Factors on the Age of Onset for Type 2 Diabetes Mellitus in Addition to the Conventional Risk Factors.

Authors:  Peter Piko; Nardos Abebe Werissa; Szilvia Fiatal; Janos Sandor; Roza Adany
Journal:  J Pers Med       Date:  2020-12-22

Review 5.  New insights into KATP channel gene mutations and neonatal diabetes mellitus.

Authors:  Tanadet Pipatpolkai; Samuel Usher; Phillip J Stansfeld; Frances M Ashcroft
Journal:  Nat Rev Endocrinol       Date:  2020-05-06       Impact factor: 43.330

Review 6.  Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?

Authors:  Sung Hoon Kim
Journal:  Diabetes Metab J       Date:  2015-12       Impact factor: 5.376

7.  Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk.

Authors:  Natascia Vedovato; Edward Cliff; Peter Proks; Varadarajan Poovazhagi; Sarah E Flanagan; Sian Ellard; Andrew T Hattersley; Frances M Ashcroft
Journal:  Diabetologia       Date:  2016-04-27       Impact factor: 10.122

8.  DNA methylation of candidate genes in peripheral blood from patients with type 2 diabetes or the metabolic syndrome.

Authors:  Sanne D van Otterdijk; Alexandra M Binder; Katarzyna Szarc Vel Szic; Julia Schwald; Karin B Michels
Journal:  PLoS One       Date:  2017-07-20       Impact factor: 3.240

Review 9.  Role of Actionable Genes in Pursuing a True Approach of Precision Medicine in Monogenic Diabetes.

Authors:  Antonella Marucci; Irene Rutigliano; Grazia Fini; Serena Pezzilli; Claudia Menzaghi; Rosa Di Paola; Vincenzo Trischitta
Journal:  Genes (Basel)       Date:  2022-01-09       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.